Oaktree Capital Management, L.P.

Lend to biotechs to bring drugs to market

I underwrite the drug itself: will people use it, and would a pharma buyer want it in a downside case?

Talk to me about
Investment Banking Associate (Healthcare) at Evercore·2021 – 2022

Worked on AstraZeneca's $39bn Alexion deal

On Evercore's biopharma M&A team I also worked on Novo Nordisk's $1.8bn Emisphere deal.

Talk to me about
Investment Banking Analyst (Services and Industrials) at William Blair·2018 – 2020

Turned law firm rejections into banking

After my UCL law degree, the law firms all rejected me, so I pivoted and started in sell-side M&A.

Talk to me about
Hong Kong

Grew up in Hong Kong, trained in accounting

My high school accounting training turned out pretty helpful when I pivoted from law into banking.

Talk to me about
Alex Chan

Alex Chan⁠

About

I lend to life sciences companies after a decade in investment banking.

Experiences

  1. Oaktree Capital Management, L.P.Lend to biotechs to bring drugs to market

    I underwrite the drug itself: will people use it, and would a pharma buyer want it in a downside case?

  2. Investment Banking Associate (Healthcare) at EvercoreWorked on AstraZeneca's $39bn Alexion deal

    On Evercore's biopharma M&A team I also worked on Novo Nordisk's $1.8bn Emisphere deal.

  3. Investment Banking Analyst (Services and Industrials) at William BlairTurned law firm rejections into banking

    After my UCL law degree, the law firms all rejected me, so I pivoted and started in sell-side M&A.

  4. Hong KongGrew up in Hong Kong, trained in accounting

    My high school accounting training turned out pretty helpful when I pivoted from law into banking.

Follow Alex for more...

LinkedIn

© 2026 Delphi · Terms · Privacy

Alex Chan

Alex Chan⁠

About

I lend to life sciences companies after a decade in investment banking.

Experiences

  1. Oaktree Capital Management, L.P.Lend to biotechs to bring drugs to market

    I underwrite the drug itself: will people use it, and would a pharma buyer want it in a downside case?

  2. Investment Banking Associate (Healthcare) at EvercoreWorked on AstraZeneca's $39bn Alexion deal

    On Evercore's biopharma M&A team I also worked on Novo Nordisk's $1.8bn Emisphere deal.

  3. Investment Banking Analyst (Services and Industrials) at William BlairTurned law firm rejections into banking

    After my UCL law degree, the law firms all rejected me, so I pivoted and started in sell-side M&A.

  4. Hong KongGrew up in Hong Kong, trained in accounting

    My high school accounting training turned out pretty helpful when I pivoted from law into banking.

Follow Alex for more...

LinkedIn

© 2026 Delphi · Terms · Privacy

By using this service, you agree to the Terms of Service and Privacy Policy.